Also found in: Medical.
MSAFPMaternal Serum Alpha-Fetoprotein
MSAFPMaternal Serum Alpha Fetoprotein Screening (American Pregnancy Association)
References in periodicals archive ?
The checking of MSAFP on 16-18 week of conception is more sensitive.
Laboratory investigations NESTROFT followed by HB A2 estimation and MSAFP were carried out in 2548 cases.
Lower than expected MSAFP levels are seen when fetal gestational age is overestimated, in maternal Type 1 diabetes, fetal Trisomy 21 (Down syndrome) or Trisomy 18 (Edward's syndrome), and in pseudopregnancy (e.
Roberson said in an interview that she was aware of a large number of institutions that allow a repeat MSAFP if the initial elevation is less than 3 MoM (approximately one-third of labs in one survery), but did not know of any other studies tracking outcomes in women given a second serum screening.
has been effected with such silence and such ease," They analyze results from their interviews with women after MSAFP screening in California.
The combination of elevated inhibin A with elevated MSAFP improves prediction of stillbirth," Dr.
Uterine artery Doppler velocimetry in the prediction of adverse obstetric outcomes in unexplained MSAFP elevations.
Indeed, Nancy Press and Carole Browner (26) found that overwhelming percentages of women agreed to take the MSAFP test, (27) and that, when asked, they had strikingly little to say about their reasons for their decision.
The optimal time for measuring MSAFP is between 16-18 weeks of gestation, but testing can be conducted as early as 15 weeks and as late as 22 weeks.
Such tests include ultrasonography, visualizing the fetus with sound waves; CVS, analyzing cells from a tiny piece removed from the placenta; MSAFP screening, checking maternal blood for the levels of three substances; arid amniocentesis, examining cells grown from fluid in the sac around the fetus, obtained via a needle through the abdomen.
The purpose of this study was to describe family physician experience with MSAFP testing and determine if physician characteristics and attitudes influence whether the test is offered and whether patients accept it.
In antiphospholipid syndrome, the MSAFP elevation follows placental thrombosis, which results from a cascade that begins with activation of endothelial cells.